• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA USA, INC. PULSE GEN MODEL 106; GENERATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA USA, INC. PULSE GEN MODEL 106; GENERATOR Back to Search Results
Model Number 106
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hypoxia (1918); Convulsion, Clonic (2222)
Event Date 12/18/2023
Event Type  Injury  
Event Description
It was reported that the patient experienced breathing issues with low oxygen.The patient was referred to a pulmonologist to confirm the reported events.The patient reports experiencing multiple hypoxia events which resolved by itself without any intervention.Information received from the physician noting that when the patient was set to normal 1ma/magnet 1ma/ autostim 1.25ma they experienced one event of hypoxia 75% without a seizure and 2 events of seizures with hypoxia.When set to normal 0.75ma/magnet 0.75ma/ autostim 1 ma they experienced a seizure with low oxygen, 89%.When set to normal 0.25ma/magnet 0.25ma/ autostim 0.25 ma they experienced a low oxygen 50% event with no seizure.No other relevant information has been received to date.
 
Manufacturer Narrative
Livanova usa, inc.Submits this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation, based on information that livanova has obtained, but may not have been able to investigate or verify prior to the date the report was required by the fda.This report does not constitute an admission, or a conclusion by fda or anyone else, that the device, livanova, or livanova's employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects¿ or "malfunctions¿.These words are incorporated into the fda 3500a medwatch form by the fda, and livanova objects to their use.
 
Event Description
Additional information received noting that the patient underwent a sleep study and she experienced a decrease in o2 saturation.The patient also reports that her seizure frequency is less, but it seems that when she has a breakthrough seizure, they are more intense, but she is able to recover more quickly.The physician just notes that the patient has anxiety (not alleged against the vns) but never had hypoxia triggered by anxiety.The physician would like to stay on the current medication and vns settings until theyre able to resolve the hypoxia issue, no additional intervention was noted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PULSE GEN MODEL 106
Type of Device
GENERATOR
Manufacturer (Section D)
LIVANOVA USA, INC.
100 cyberonics blvd
houston TX 77058
Manufacturer (Section G)
LIVANOVA USA, INC.
100 cyberonics blvd
suite 600
houston TX 77058
Manufacturer Contact
cindy scott
100 cyberonics blvd
suite 600
houston, TX 77058
2816672681
MDR Report Key18544756
MDR Text Key333264839
Report Number1644487-2024-00061
Device Sequence Number1
Product Code LYJ
UDI-Device Identifier05425025750061
UDI-Public05425025750061
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P970003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/01/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model Number106
Device Lot Number834
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Event Location Other
Initial Date Manufacturer Received 12/27/2023
Initial Date FDA Received01/19/2024
Supplement Dates Manufacturer Received02/12/2024
Supplement Dates FDA Received03/01/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/06/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age30 YR
Patient SexFemale
-
-